Pharmaceutical preparations for treatment of convulsion; Therapeutic injectable pharmaceuticals for muscles; Preparations for treatment of sarcopenia; Pharmaceutical preparations for treatment of cerebral palsy; Pharmaceutical preparations for treatment of hyperhidrosis; Pharmaceutical preparations for treatment of headache; Pharmaceutical preparations for treatment of trembling disorder; Pharmaceutical preparations for treatment of neurological disorder; Injectable pharmaceuticals for treatment of ligaments; Pharmaceutical preparations for treatment of autonomic nervous system disease; Pharmaceutical preparations for treatment of wrinkly skin syndrome; Analgesics; Injectable pharmaceuticals for treatment of tendon; Pharmaceutical preparations namely, botolinium toxin; Pharmaceutical preparations for treatment of smooth muscle disease; Pharmaceutical preparations for treating myotony; Pharmaceutical preparations for treating sports injuries; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Adjuvants for medical purposes; Drugs for medical purposes; Pharmaceutical preparations for central nerve treatment; Pharmaceutical preparations for chemical disorder treatment; Pharmaceutical preparations for diagnosis; Chemicals for pharmaceutical use; Medicines for human purposes.
FORMALIZED
on 15 Sep 2021
BTSA9(LOGO)
PROTOX INC.
2133385 · 15 Sep 2021
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for treatment of convulsion; Therapeutic injectable pharmaceuticals for muscles; Preparations for treatment of sarcopenia; Pharmaceutical preparations for treatment of cerebral palsy; Pharmaceutical preparations for treatment of hyperhidrosis; Pharmaceutical preparations for treatment of headache; Pharmaceutical preparations for treatment of trembling disorder; Pharmaceutical preparations for treatment of neurological disorder; Injectable pharmaceuticals for treatment of ligaments; Pharmaceutical preparations for treatment of autonomic nervous system disease; Pharmaceutical preparations for treatment of wrinkly skin syndrome; Analgesics; Injectable pharmaceuticals for treatment of tendon; Pharmaceutical preparations namely, botolinium toxin; Pharmaceutical preparations for treatment of smooth muscle disease; Pharmaceutical preparations for treating myotony; Pharmaceutical preparations for treating sports injuries; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Adjuvants for medical purposes; Drugs for medical purposes; Pharmaceutical preparations for central nerve treatment; Pharmaceutical preparations for chemical disorder treatment; Pharmaceutical preparations for diagnosis; Chemicals for pharmaceutical use; Medicines for human purposes.
Pharmaceutical preparations for treatment of convulsion; Therapeutic i...